Literature DB >> 1770532

Substitution of cysteine for glycine at residue 415 of one allele of the alpha 1(I) chain of type I procollagen in type III/IV osteogenesis imperfecta.

A C Nicholls1, J Oliver, D V Renouf, M Keston, F M Pope.   

Abstract

We have examined the type I collagen in a patient with type III/IV osteogenesis imperfecta. Two forms of alpha 1(I) chain were produced, one normal and the other containing a cysteine residue within the triple helical domain of the molecule. Cysteine is not normally present in this domain of type I collagen. Peptide mapping experiments localised the mutation to peptide alpha 1(I)CB3 which spans residues 403 to 551 of the triple helix. Subsequent PCR amplification of cDNA covering this region followed by sequencing showed a G to T single base change in the GGC codon for glycine 415 generating TGC, the codon for cysteine. The effect of the mutation on the protein is to delay secretion from the cell, reduce the thermal stability of the molecule by 2 degrees C, and cause excessive post-translational modification of all chains in molecules containing one or more mutant alpha 1(I) chains. The clinical phenotype observed in this patient and the position of the mutation conform to the recent prediction of Starman et al that Gly----Cys mutations in the alpha 1(I) chain have a gradient of severity decreasing from the C-terminus to the N-terminus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1770532      PMCID: PMC1017111          DOI: 10.1136/jmg.28.11.757

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  28 in total

1.  Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele.

Authors:  D H Cohn; P H Byers; B Steinmann; R E Gelinas
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  A single base mutation that converts glycine 907 of the alpha 2(I) chain of type I procollagen to aspartate in a lethal variant of osteogenesis imperfecta. The single amino acid substitution near the carboxyl terminus destabilizes the whole triple helix.

Authors:  C T Baldwin; C D Constantinou; K W Dumars; D J Prockop
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

3.  Linkage of a polymorphic marker for the type III collagen gene (COL3A1) to atypical autosomal dominant Ehlers-Danlos syndrome type IV in a large Belgian pedigree.

Authors:  A C Nicholls; A De Paepe; P Narcisi; R Dalgleish; F De Keyser; M Matton; F M Pope
Journal:  Hum Genet       Date:  1988-03       Impact factor: 4.132

Review 4.  DNA replication.

Authors:  A Kornberg
Journal:  J Biol Chem       Date:  1988-01-05       Impact factor: 5.157

5.  A 19-base pair deletion in the pro-alpha 2(I) gene of type I procollagen that causes in-frame RNA splicing from exon 10 to exon 12 in a proband with atypical osteogenesis imperfecta and in his asymptomatic mother.

Authors:  H Kuivaniemi; C Sabol; G Tromp; M Sippola-Thiele; D J Prockop
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

6.  Ehlers-Danlos syndrome type VII: a single base change that causes exon skipping in the type I collagen alpha 2(I) chain.

Authors:  A C Nicholls; J Oliver; D V Renouf; J McPheat; A Palan; F M Pope
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

7.  A cysteine for glycine substitution at position 1017 in an alpha 1(I) chain of type I collagen in a patient with mild dominantly inherited osteogenesis imperfecta.

Authors:  M E Labhard; M K Wirtz; F M Pope; A C Nicholls; D W Hollister
Journal:  Mol Biol Med       Date:  1988-12

8.  Arginine for glycine substitution in the triple-helical domain of the products of one alpha 2(I) collagen allele (COL1A2) produces the osteogenesis imperfecta type IV phenotype.

Authors:  R J Wenstrup; D H Cohn; T Cohen; P H Byers
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

9.  Osteogenesis imperfecta type IV. Detection of a point mutation in one alpha 1(I) collagen allele (COL1A1) by RNA/RNA hybrid analysis.

Authors:  J C Marini; D K Grange; G S Gottesman; M B Lewis; D A Koeplin
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

10.  Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.

Authors:  B J Starman; D Eyre; H Charbonneau; M Harrylock; M A Weis; L Weiss; J M Graham; P H Byers
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

View more
  2 in total

1.  New restriction endonuclease CviRI cleaves DNA at TG/CA sequences.

Authors:  A Jin; Y Zhang; Y Xia; E Traylor; M Nelson; J L Van Etten
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

Review 2.  Molecular Basis of Pathogenic Variants in the Fibrillar Collagens.

Authors:  Allan J Richards; Martin P Snead
Journal:  Genes (Basel)       Date:  2022-07-04       Impact factor: 4.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.